Daniel L. Goodwin’s Merck MRK Stock Holding History

Daniel L. Goodwin’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400	Closed	-$33K	–	104
2022 Q1	$33K	Buy	+400	New	+$31.5K	0.01%	102

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Daniel L. Goodwin's MRK Position: Q2 2022 in Review

Daniel L. Goodwin sold out of Merck (MRK) in Q2 2022, closing a stake of 400 shares — an estimated $33K sold.

Daniel L. Goodwin first reported a position in MRK in Q1 2022 and held it in 1 quarter. The position peaked at $33K in Q1 2022. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

Daniel L. Goodwin reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
Daniel L. Goodwin sold 400 Merck shares in Q2 2022, an estimated $33K.
Daniel L. Goodwin first reported a position in Merck in Q1 2022 and held it in 1 quarter.
Daniel L. Goodwin's Merck position peaked at $33K in Q1 2022.
3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Daniel L. Goodwin's 13F filing for Q2 2022, filed 22 Jul 2022.